Bladder Cancer Clinical Trial

Near Infrared Fluorescence Imaging for Bladder Cancer Detection

Summary

The primary outcome of this study is to determine the minimal dwell time needed for adequate detection of hexaminolevinulate HCL avid tumors using protoporphyrin IX (PpIX) near infrared fluorescence (NIRF).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Diagnosis of bladder mass on office cystoscopy suspicious for malignancy, either newly diagnosed or a recurrent tumor.
Planned transurethral resection of bladder tumor in the operating room.
Ability to give informed consent.
Willing to spend time for the study
Men or women (age 18 or older)
Any racial or ethnic origin

Exclusion Criteria:

Pregnancy
Nursing mother
Diagnosis of porphyria
Gross hematuria
BCG immunotherapy or intravesical chemotherapy within the past 90 days
Known hypersensitivity to hexaminolevulinate or any derivative of aminolevulinic acid

Study is for people with:

Bladder Cancer

Estimated Enrollment:

10

Study ID:

NCT03058705

Recruitment Status:

Completed

Sponsor:

Edward Messing

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Rochester Medical Center
Rochester New York, 14642, United States

How clear is this clinincal trial information?

Study is for people with:

Bladder Cancer

Estimated Enrollment:

10

Study ID:

NCT03058705

Recruitment Status:

Completed

Sponsor:


Edward Messing

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider